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The TRansport Protein Particle (TRAPP) complex is a multimolecular 
complex controlling membrane trafficking along the secretory, endocytic 
and autophagic pathways. With its multiple sites of action, TRAPP is in a 
strategic position to integrate the trafficking activity along these pathways 
in response to different cellular needs. By analyzing the response to 
different stress stimuli, we identified in TRAPP a key component of stress 
granules (SGs), membrane-less organelles that assemble in response to 
stress.  
We provide different lines of evidence supporting a pivotal role for TRAPP 
in SG composition and function and in the integrated stress response.  Firstly, 
the association of TRAPP with SGs orchestrates the adaptation to stress of 
the secretory pathway by inducing a slow-down of protein export from the 
ER (by trapping COPII on SGs) and the fragmentation of the Golgi complex 
(due to Rab1 inactivation, since TRAPP is a Rab1 GEF).  Secondly, it increases 
the overall cell resistance to stress as it mediates the sequestering to SGs of 
pro-apoptotic factors (such as RACK1).  Finally, the partitioning of TRAPP to 
SGs presents unique features, being under the control of cyclin-dependent 
kinase 1 and 2 and coupled with the cytosol-membrane cycle of TRAPP and 
COPII at ER exit sites. This renders the association of TRAPP with SGs, and 
thus the composition and function of the SGs themselves, finely tuned and 
conditional on the cell growth rate and the activity of the early secretory 
pathway.  
Altogether, our findings reveal a new feature of SGs that is acquired through 
the recruitment of TRAPP: a high grade of plasticity that tailors their 
composition and function to different cellular metabolic, growth or activity 
states. 
 
 
Introduction 
The TRAPP (transport protein particle) complex is a conserved multimolecular 
complex intervening in multiple segments of membrane trafficking along the 
secretory, the endocytic and the autophagy pathways (Kim et al., 2016). 
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Originally identified in yeast as a tethering factor acting in ER-to-Golgi trafficking, 
it was subsequently discovered to act as a GEF for Ypt1 and Ypt31/32 in yeast and 
for Rab1 and possibly Rab11 in mammals (Westlake et al., 2011; Yamasaki et al., 
2009; Zou et al., 2012). The TRAPP complex has a modular composition, and is 
present as two forms in mammals: TRAPPII and TRAPPIII which share a common 
heptameric core (TRAPPC1, TRAPPC2, TRAPPC2L, TRAPPC3, TRAPPC4, TRAPPC5, 
TRAPPC6) and additional subunits specific for TRAPPII (TRAPPC9/ TRAPPC10) 
or for TRAPPIII (TRAPPC8, TRAPPC11, TRAPPC12, TRAPPC13) (Sacher et al., 
2018). TRAPPII has been implicated in late Golgi trafficking while TRAPPIII has a 
conserved role in the early secretory pathway (ER-to-Golgi) and in autophagy 
Yamasaki (Scrivens et al., 2011; Yamasaki et al., 2009). Recent lines of evidence 
have expanded the range of activities of the TRAPP complex by showing that it 
takes part in a cell survival response triggered by agents that disrupt the Golgi 
complex (Ramírez-Peinado et al., 2017)and can drive the assembly of lipid 
droplets in response to lipid load (Li et al., 2017). 
 
The importance of the TRAPP complex in humans is testified by the deleterious 
consequences caused by mutations in genes encoding distinct TRAPP subunits. 
Mutations in TRAPPC2L, TRAPPC6A, TRAPPC6B, TRAPPC9 and TRAPPC12 cause 
neurodevelopmental disorders leading to intellectual disability and dysmorphic 
syndromes (Harripaul et al., 2018; Khattak and Mir, 2014; Milev et al., 2018, 2017, 
p. 12; Mohamoud et al., 2018), mutations in TRAPPC11 lead to ataxia (Koehler et 
al., 2017), and mutations in TRAPPC2 lead to the spondyloepiphyseal dysplasia 
tarda (SEDT) (Gedeon et al., 1999). 
SEDT is characterized by short stature, platyspondyly, barrel chest and premature 
osteoarthritis that manifest in late childhood/prepubertal age. We have shown 
that pathogenic mutations or deletion of TRAPPC2 alter the ER export of 
procollagen (both type I and type II) and that TRAPPC2 interacts with the 
procollagen escort protein TANGO1 and regulates the cycle of the GTPase Sar1 at 
the ER exit sites (ERES; (Venditti et al., 2012)). The Sar1 cycle in turn drives the 
cycle of the COPII coat complex, which mediates the formation of carriers 
containing neo-synthesized cargo to be transported to the Golgi complex. While 
this role of TRAPPC2 in the ER export of PC might explain the altered ECM 
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deposition observed in patients cartilage (Venditti et al., 2012; Tiller et al., 2001), 
it leaves unexplained the late onset of the disease signs as well as the development 
of precocious osteoarthritis. We hypothesized that the latter could be due to an 
inability to maintain long-term cartilage tissue homeostasis, possibly due to an 
impaired capacity of chondrocytes to face the physiological stresses that underlie 
and guide their development and growth. These include mechanical stress that 
can induce oxidative stress leading to apoptosis (Henrotin et al., 2003; Zuscik et 
al., 2008). 
Indeed, the TRAPP complex, with its multiple sites of action along the secretory 
and autophagic pathways and its multiple molecular partners (including COPII 
and COPI), occupies a strategic position to integrate the activities along these 
pathways in response to different stimuli including physiological and pathological 
stressors.  Here, by analyzing the cell response to different stresses, we show that 
the TRAPP complex is a component of stress granules (SGs), membrane-less 
organelles that assemble in response to stress (Protter and Parker, 2016). The 
recruitment of TRAPP to SGs has multiple impacts on the stress response as it 
induces the sequestration of Sec23/Sec24 (the inner layer of the COPII complex) 
onto SGs thus inhibiting trafficking along the early secretory pathway, leads to the 
inactivation of the small GTPase Rab1 with a consequent disorganization of the 
Golgi complex, and is required for the recruitment of signalling proteins, such as 
RACK1, to SGs thus contributing to the anti-apoptotic role of SGs. Interestingly, 
TRAPP and COPII recruitment to SGs only occurs in actively proliferating cells and 
is under control of cyclin-dependent-kinases (CDK 1 and 2). We identified in Sec31 
one of the Cdk targets that is able to modulate the COPII cycle at the ERES. CDK 
inhibition stabilizes TRAPP and COPII at the ERES and reduces their cytosolic pool, 
i.e, the one that is sequestered onto SGs.  
In conclusion, we highlight a hitherto undisclosed property of SGs: a differential 
and modular composition dependent on cell growth activity that reflects the 
ability of cells to commensurate their response to stress to their proliferation state 
and energy demands., and we have identified in the TRAPP complex a key element 
in conferring this adaptive plasticity to SG. 
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Results 
 
TRAPP redistributes to SGs in response to different stress stimuli 
TRAPP components such as TRAPPC2 and TRAPPC3 have been shown to be 
associated with ERES under steady state conditions (Venditti et al., 2012). We 
found that exposure of chondrocytes (Figure 1A) or HeLa cells (Figure 1B) to an 
oxidative stress such as treatment with sodium arsenite (SA) led to dissociation of 
TRAPPC2 from ERES and a strong relocalization to roundish structures. Since 
oxidative stress is known to lead to the formation of stress granules (SGs; 
Anderson and Kedersha, 2002), we considered the possibility that these 
TRAPPC2-positive structures might be SGs. Indeed, co-labeling with an anti-eIF3 
antibody, a canonical SG marker (Aulas et al., 2017), showed the co-localization of 
TRAPPC2 with eIF3 after SA treatment (Figure 1A,B). Other TRAPP components, 
such as TRAPPC1 and TRAPPC3, exhibited the same response to SA treatment 
(Figure 1C). TRAPP recruitment to SGs occurs also in response to heat shock 
(Figure 1—figure supplement 1A), and in different cell lines (Figure 1—figure 
supplement 1B,C). This appears to be a conserved process since it also occurs in 
yeast cells exposed to heat stress (Figure 1—figure supplement 2, Figure 1—
supplement video 1 and 2). Of note, the association of TRAPP with SGs is fully 
reversible after stress removal (Figure 1—figure supplement 3). 
We followed the dynamics of TRAPPC2 redistribution to SGs in response to stress. 
The appearance of eIF3-positive SGs occurred 7 min after SA treatment (Figure 
1D). TRAPPC2 re-localization to SG began 15 min after the exposure to stress and 
gradually increased over time, with massive recruitment occurring 60 min after 
treatment, and thus lagged behind the initial assembly of SGs (Figure 1D).  
We analyzed the TRAPP complex by gel filtration and found that the oxidative 
stress did not affect the overall integrity of the complex. However, TRAPP 
components were also found in higher molecular weight fractions in stressed cells 
(Figure 1E) possibly reflecting the SG-associated TRAPP since the same fractions 
also contained the SG component TIAR-1 (Figure 1E). Together, these results led 
us to conclude that following stress the TRAPP complex becomes a SG component. 
 
TRAPPC2 is required for recruiting COPII to SGs 
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The translocation of TRAPP to SGs prompted us to investigate whether other 
components of membrane trafficking machineries behaved similarly. We 
screened different coat complex components (COPI, COPII, clathrin adaptors, 
clathrin), and other cytosolic proteins associated with the exocytic and endocytic 
pathways. Out of the 15 proteins tested, only components of the inner layer of the 
COPII coat, Sec24 (Figure 2A, B) and Sec23 (Figure 2—figure supplement 1A), but 
none of the others (Figure 2C, and Figure 2—figure supplement 1B-N, Figure 2—
figure supplement 2) associated with SGs. Notably, Sec24 was recruited to SGs 
with kinetics similar to those of the TRAPP complex (Figure 2A). 
Since TRAPP and COPII are known to interact and TRAPP is recruited to ERES in a 
Sar1- and COPII-dependent manner (Lord et al., 2011; Venditti et al., 2012), we 
asked whether COPII and TRAPP recruitment to SGs is interdependent. The 
depletion of the COPII inner layer proteins Sec23 and Sec24 had no impact on the 
recruitment of the TRAPP complex to SGs (Figure 2D,E) while the depletion of the 
entire TRAPP complex (by KD of TRAPPC3, which destabilizes the entire complex,) 
or of the TRAPPC2 subunit (by KD of TRAPPC2 that leaves unaltered the rest of 
the TRAPP complex, (Venditti et al., 2012)) abrogated the recruitment of COPII 
components to SGs (Figure 2F). We also noted that TRAPP-KD resulted in smaller 
SGs, a phenomenon that is analyzed in more detail below. These results indicated 
that the TRAPP complex, through its component TRAPPC2, drives the recruitment 
of COPII to SGs.  
COPII components have been reported to associate with membrane-less 
organelles called “Sec bodies” in Drosophila S2 cells (Zacharogianni et al., 2014)  . 
Sec bodies, however, form in response to prolonged starvation (but not to 
oxidative stress) and are distinct from SGs since they do not contain 
ribonucleoproteins (RNPs). The recruitment of COPII to Sec bodies in Drosophila 
depends on Sec16, another component of ERES. However, we found that in 
mammalian cells Sec16 neither significantly associates with SGs (Figure 2—figure 
supplement 2A,B) nor is it required for the recruitment of COPII to SGs (Figure 
2—figure supplement 2C). 
COPII proteins exhibit dynamic association/dissociation with ERES membranes 
(D’Arcangelo et al., 2013). An indirect assessment of the membrane-cytosol cycle 
of the endogenous COPII components may be obtained by evaluating their leakage 
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from permeabilized cells (Kapetanovich et al., 2005), as the extent of leakage is 
proportional to the rate of membrane dissociation. Under steady state conditions, 
the majority of COPII components is lost from cells 6 min after permeabilization 
(Figure 3A). By contrast, COPII remained associated with SGs in permeabilized SA-
treated cells (Figure 3A), indicating that the SG-associated pool of COPII is much 
less dynamic than the ERES-associated pool. 
We then assessed the relationship between the pool of COPII/TRAPP cycling at 
the ERES and that recruited to SGs. To this end we stabilized the ERES association 
of COPII and TRAPP by expressing either a constitutively active GTP-bound Sar1 
mutant (Sar1-H79G) or decreasing the rate of GTP hydrolysis on Sar1 by depleting 
Sec31, which is a co-GAP that potentiates by an order of magnitude the Sar1 GAP 
activity of Sec23-24 (Bi et al., 2007). Under both conditions COPII and TRAPP were 
more tightly associated with ERES, while their translocation to SGs upon exposure 
to stress was significantly reduced (Figure 3B,C). Thus, the extent of COPII/TRAPP 
recruitment to SG depends on the rate of its cycling at the ERES.   
 
The association of TRAPP is under the control of CDK1/2 
To investigate the mechanisms that could mediate the recruitment of TRAPP to 
SGs, we performed a proteomics analysis of the TRAPPC2 interactors (see 
Materials and methods). This analysis (Figure 4A, Table), while confirming the 
known interactors of TRAPPC2 (e.g. TRAPP complex components, Rab1, COPII and 
COPI), revealed the presence of many RNA binding proteins (RBPs), including 
those with a central role in the assembly of SGs (Jain et al., 2016). Both known 
interactors and some RBPs were confirmed by Western blot analysis (Figure 4—
figure supplement 1). This suggested that, as described for other components of 
SGs, TRAPPC2 may be recruited to growing SGs by a piggyback mechanism 
(Anderson and Kedersha, 2008), i.e. via the interaction with RBPs that are 
components of SGs. 
We next looked for the mechanisms regulating this recruitment. To dissect the 
regulation of TRAPP/COPII recruitment to SGs, we screened a library of kinase 
inhibitors for their ability to affect the re-localization of COPII to SGs. HeLa cells 
were pre-treated with kinase inhibitors for 150 min and then exposed to SA for a 
further 30 min in the continuous presence of the inhibitors. Out of the 273 
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inhibitors tested, 194 had no effect on SG formation or on COPII recruitment, 13 
were generally toxic (65% mortality) at the tested concentrations, one (AZD4547) 
affected the formation of SGs, while the remaining 32 specifically inhibited (by at 
least 35%) the association of Sec24C with SGs without affecting SG formation 
(Figure 4B). Enrichment analysis on this last group of inhibitors highlighted that 
CDK inhibitors were the most represented class (Figure 4C). Western blot analysis 
confirmed that CDK activity was impaired in cells treated with the CDK inhibitors 
(Figure 4D). In addition, we observed that there is an increase in CDK activity in 
SA-treated cells that was sensitive to CDK inhibitors (Figure 4D).  
The CDK protein kinase family is composed of 21 members (Malumbres, 2014) 
but the available inhibitors have limited selectivity (Asghar et al., 2015). To 
identify which specific CDK might be involved in Sec24C recruitment, we 
compared the potency of the CDK inhibitors (Flavopiridol hydrochloride, SNS-
032, Dinaciclib, AT7519, PHA-793887, ADZ5438, JNJ-7706621, PHA-767491, 
BMS-265246, PHA-848125, Roscovitine, Palbociclib, BS-181HCl) in the Sec24C 
recruitment assay with their ability to inhibit the different CDK isoforms, as 
described by Selleckchem (https://www.selleckchem.com/CDK.html). This 
analysis revealed that CDK1 and 2 were the ones commonly targeted by the 
inhibitors that most potently affected Sec24C recruitment to SGs (Figure 5A), thus 
suggesting that CDK1/2 are the most likely CDKs controlling COPII recruitment to 
SGs. This was confirmed by the observation that down-regulating the expression 
of CDK1 and CDK2 by siRNA inhibited COPII recruitment to SGs (Figure 5B). The 
three best hits (Flavopiridol, Dinaciclib, SNS032, Figure 5A,C) were assayed using 
a dose-response analysis and were found to be effective at concentrations as low 
as 100 nM (Figure 5D), thus speaking in favor of a specific effect on CDK1/2. As a 
negative control, the specific CDK7 inhibitor (BS-181HCl) was ineffective, even at 
the highest concentration tested (Figure 5D).  
Since COPII recruitment to SGs is driven by TRAPP recruitment (Figure 2F), we 
hypothesized that CDK1/2 inhibitors would also inhibit TRAPP recruitment. In 
line with our expectations, TRAPP re-localization to SGs was reduced in cells 
treated with CDK1/2 inhibitors (Figure 5E).  
Altogether, these results indicate that a signaling pathway mediated by CDK1/2 
controls the recruitment of TRAPP and COPII to SGs. 
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The recruitment of TRAPP and COPII to SGs occurs in actively proliferating 
cells 
The observation that the recruitment of TRAPP and COPII to SGs is under control 
of CDK1/2 suggested that it could be linked to the cell proliferation. We explored 
this possibility by decreasing the cell proliferation rate in different and 
independent ways: by reducing nutrient availability, by increasing cell confluence, 
or by inducing a switch from a proliferation to a differentiation state.   
First, cells were subjected to prolonged nutrient starvation (HBSS for 8 hr) and 
then were exposed to SA for 30 min. Under these conditions, which inhibited cell 
proliferation, TRAPP/COPII association with SGs was reduced, while SGs formed 
regularly (Figure 6A,B).  
Second, HeLa cells were seeded at different confluency and then treated with AS 
for 30 min. Strikingly, the extent of confluency was inversely related to the extent 
of TRAPP/COPII association with SGs and to the degree of proliferation (Figure 
6C). 
Third, we monitored the recruitment of TRAPP/COPII to SGs in podocyte cells 
expressing a temperature sensitive LTA-SV40 that actively proliferate at the 
permissive temperature of 33ºC but arrest proliferation and differentiate at the 
restrictive temperature of 37ºC (Saleem et al., 2002) (Figure 6D, Figure 6—figure 
supplement 1). While TRAPP and COPII associate with SGs in undifferentiated 
podocytes in response to stress, this association was reduced in differentiated 
podocytes (Figure 6E). Of note, the proliferation to differentiation switch, as 
described (Saurus et al., 2016), is also accompanied by a decline in CDK activity 
(Figure 6F). These data indicate that the association of COPII and TRAPP with SGs 
occurs only in proliferating cells and requires active CDK1/2 signaling. 
 
CDK1 and 2 control TRAPP/COPII recruitment to SGs by modulating their 
cycle at the ERES. 
We next investigated the nature and the possible target(s) of the pathway 
involving CDK1/2 that controls the recruitment of TRAPP/COPII complexes to SGs. 
As shown above (Figure 3), the recruitment of TRAPP/COPII to SGs is conditioned 
by the dynamics of the COPII cycle at ERES. We hypothesized that CDK inhibition 
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might prevent the recruitment of TRAPP/COPII to SGs by stabilizing their 
association with the ERES. Indeed, we found that the pool of TRAPP and COPII 
associated with ERES is higher, while the cytosolic pool of the two complexes is 
reduced, in cells treated with the CDK1/2 inhibitors as compared to untreated 
cells (Figure 7A). The analysis of the pool associated at ERES by a permeabilization 
assay confirmed that the CDK1/2 inhibitors strongly increased the amount of 
COPII associated with ER membranes-(Figure 7B,C). 
 
To understand how CDK1/2 might affect the COPII cycle at the ERES, which in turn 
is dependent on the cycling of the small GTPase Sar1, we focused on Sec31 as a 
possible target for a number of considerations. First, Sec31 is required for proper 
Sar1 cycling at the ERES (Bi et al., 2007); second we have shown that Sec31 is 
required for the translocation of COPII/TRAPP to SG (Figure 3C).; finally, Sec31 is 
a target of CDKs in yeast (Holt et al., 2009) and in Trypanosoma brucei where it 
has been shown that Sec31 phosphorylation by CRK1 (the CDK ortholog in T. 
brucei) is required for anterograde trafficking (Hu et al., 2016). In mammals, Sec31 
activity is modulated by post-translational modifications including 
phosphorylation on multiple sites (Koreishi et al., 2013) one of which (serine 799) 
is included in a consensus motif for CDK phosphorylation. We tested whether 
Sec31 could be a substrate for CDK using an antibody specific for phosphoSer CDK 
substrates. We found that Sec31 is indeed a target for CDKs (Figure 7D), and that 
its CDK-dependent phosphorylation is increased upon SA treatment and 
decreased by the CDK inhibitor Dinaciclib (Fig. 7D). A further correlation between 
the phosphorylation of Sec31 and the recruitment of COPII and TRAPP to SGs is 
provided by the observation that the extent of CDK-dependent phosphorylation is 
dampened in differentiated as compared with proliferating podocytes (Figure 7E). 
Altogether, the above results suggest that phosphorylation of Sec31 by CDKs 
might modulate COPII membrane association thus regulating the availability of 
the cytosolic pool able to phase-separate to SGs. 
 
The recruitment of TRAPP and COPII to SGs slows down ER export and 
induces the fragmentation of the Golgi complex 
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We investigated the impact of the recruitment to TRAPP/COPII to SGs on the 
secretory pathway.  
We first analysed the ER export of procollagen type I (PC-I), which is known to be 
regulated by COPII and TRAPP (Gorur et al., 2017; Venditti et al., 2012). PC-I 
transport can be synchronized by temperature, being unfolded and blocked in the 
ER at 40°C while properly folded and assembled and able to be exported from the 
ER, transported to the Golgi complex (GC) and secreted at 32°C ((Mironov et al., 
2001) and Methods). Note that incubation at 40°C does not cause SG aggregation. 
Human fibroblasts were incubated at 40°C, left untreated or treated with SA, 
which induces the recruitment of Sec24C to SGs (Figure 8A). PC-I is blocked in the 
ER under both conditions (Figure 8A). Monitoring of PC-I transport after the shift 
to 32°C showed that while PCI reaches the GC in untreated cells, it remains blocked 
in the ER in SA-treated cells (Figure 8A).  
To investigate to what extent the inhibition of cargo export from the ER induced 
by oxidative stress is dependent on COPII/TRAPP sequestering onto SGs, we 
developed an assay based on the use of an engineered form of a reporter cargo 
(Chen et al., 2013) whose exit from the ER is inducible by UV light. We compared 
the ER export of VSVG in control cells and in SA-treated cells either under 
conditions that induce a strong recruitment of COPII/TRAPP to SGs (SA treatment 
for 30 min) or under conditions that induce SG formation but attenuate this 
recruitment (SA treatment for 10 min). After UV light induction, VSV-G exited the 
ER and reached the Golgi complex to comparable extent in control cells and in cells 
treated with SA under conditions that attenuate the recruitment of COPII to SGs, 
while the ER export of VSVG in response to UV light was severely retarded in cells 
treated with SA under conditions where COPII was strongly recruited to SGs 
(Figure 8B, D).  
We then tested whether COPII and TRAPP maintain their functionality once 
released from SGs upon stress removal, which can be dissolved after washout of 
SA, as mentioned above (Figure 1—figure supplement 3). Cells were treated with 
SA for 30 min, the SA was washed out, and cells were left to recover for 180 min 
in the presence of cycloheximide to prevent de novo synthesis of TRAPP and COPII 
components. Under these conditions SGs were resolved, COPII returned to its 
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native location (ERES/cytosol) and cells completely recovered their capability to 
transport cargo to the Golgi apparatus (Figure 8C,D). These data indicate that 
sequestration of COPII/TRAPP onto SGs halts ER-to-Golgi trafficking while 
removal of the stress releases COPII/TRAPP and allows trafficking to resume. 
COPII and TRAPP not only control ER export but are also needed to maintain the 
organization of the GC. In particular, the TRAPP complex acts as GEF for Rab1, a 
GTPase with a key role in the organization and function of the GC (Tisdale et al., 
1992; Wilson et al., 1994). We monitored Golgi complex morphology in response 
to SA by following the distribution of the early Golgi marker GM130. Strikingly, the 
GC starts to fragment after 30 min and completely redistributes throughout the 
cytoplasm after 60 min of SA treatment (Figure 9A). This time window overlaps 
with the progressive recruitment of the TRAPP complex onto SGs (Figure 1D). To 
assess whether the Golgi fragmentation induced by oxidative stress was due to 
sequestration of TRAPP/COPII onto SGs, we analyzed the morphology of the GC in 
cells exposed to oxidative stress under conditions that prevent COPII/TRAPP 
recruitment to SGs, i.e. treatment with CDK inhibitors or highly confluent cells. We 
found that CDK inhibitors prevented the fragmentation of the GC in cells exposed 
to oxidative stress (Figure 9B), and that oxidative stress had no impact on the 
organization of the Golgi complex in highly confluent cells (Figure 8C). These 
results indicated a causal link between TRAPP/COPII sequestration to SGs and 
Golgi fragmentation. 
To gain insight into the nature of the fragmentation of the Golgi complex, we 
performed ultrastructural analysis that revealed the presence of residual swollen 
cisternae with the loss of stacked structures and extensive vesiculation in SA-
treated cells (Figure 9D), a situation that is reminiscent of the effect of Rab1 
inactivation (Wilson et al., 1994). We hypothesized that the dismantling of the 
Golgi complex could have been due to impaired Rab1 activation as a consequence 
of TRAPP (the Rab1 GEF) sequestering to SGs. We monitored Rab1 activity by 
using an antibody that specifically recognizes the GTP-bound Rab1 and found, 
indeed, that the fraction of active Rab1 (i.e. the GTP-bound form) is progressively 
reduced in cells exposed to SA (Figure 9E). Overexpression of wt Rab1 reduced 
fragmentation/vesiculation of the GC induced by oxidative stress without 
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affecting the capacity of TRAPP to migrate to SGs (Figure 9F, Figure 9—figure 
supplement 1), establishing a causal a link between Rab1 inactivation and Golgi 
fragmentation. 
The TRAPP complex imposes SG size, composition, and function 
We finally investigated whether TRAPP is an inert component of SGs or whether 
it plays any role in their assembly/function. Indeed, as noted above (Figure 2F), 
TRAPP-KD resulted in smaller and more numerous SGs, suggesting that the TRAPP 
complex could exert a role in the overall composition and function of SGs. 
Depleting the entire TRAPP complex or only TRAPPC2 (through siRNA-mediated 
depletion) decreased the size of SGs (Figure 2F and Figure 10A). Microinjection of 
a TRAPPC3-blocking Ab  (Yu et al., 2006; Venditti et al., 2012) had a similar effect 
(Figure 10B). Under these conditions the size of the SGs recall that of “immature 
SGs” (Wheeler et al., 2016). 
In fact the processes that lead to SG nucleation, i.e. impaired protein synthesis or 
phosphorylation of eIF2alpha induced by oxidative stress, were not affected by 
TRAPP depletion (Figure 10—figure supplement 1A,B). Instead, the successive 
increase in size of the nucleated SGs (i.e. SG maturation) was impaired in TRAPP 
depleted cells, consistent with our observation that TRAPP is recruited after the 
initial formation of SGs and occupies an outer position in the SGs (figure 10C). A 
feature of SG maturation is the acquisition of an array of signaling molecules 
(which can be either hyperactivated or deactivated) to drive the pro-survival 
program. This is the case of the energy sensor mTORC1 (through the 
sequestration of its partner Raptor) and the kinase RACK1 (Arimoto et al., 2008; 
Thedieck et al., 2013). To evaluate whether the absence of TRAPP could affect SG 
maturation and/or signaling function by interfering with the recruitment of these 
proteins, we checked the localization of Raptor (Figure 10D) and RACK1 (Figure 
10E, Figure 10—figure supplement 2) in TRAPP- and or TRAPPC2-depleted cells 
subjected to oxidative stress. We observed that the amount of these signaling 
proteins sequestered to SGs was strongly reduced by TRAPP depletion, thus 
indicating that the TRAPP complex is necessary to generate “mature” SGs that can 
accomplish a fully functional stress response. Localization of RACK1 and Raptor 
was also evaluated in a context of CDK inhibition. Again, treatment with CDK 
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inhibitors strongly reduced Raptor (Figure 10F) and RACK1 (Figure 10G) 
sequestration, further supporting that the TRAPP complex is needed for SG 
maturation.  
SGs are part of a pro-survival program that aims to save energy to cope with stress 
insults. Interfering with this program by impairing SG formation sensitizes cells to 
apoptosis (Takahashi et al., 2013). We thus assayed stress resistance in cells with 
an impaired capability to recruit TRAPP to SGs, i.e. upon CDK inhibition. As shown 
in Figure 10H, CDK inhibition significantly sensitized cells to cell death, indicating 
that the presence of TRAPP at SGs is required for their anti-apoptotic role and 
highlighting the TRAPP complex as a novel player in the cell response to stress.  
Discussion 
 
We have described a branch of the integrated stress response that is dependent 
on the assembly of SGs and leads to a slow-down of ER export and disorganization 
of the Golgi complex. A key component of this branch is the TRAPP complex, a 
multimolecular complex that intervenes in multiple membrane trafficking steps. 
 
We have shown that TRAPP is massively recruited to SGs in response to different 
acute stress stimuli and in turn recruits the inner layer of the COPII complex, the 
protein complex that drives the export of newly synthesized proteins from the ER, 
to SGs.  The mechanism underlying the recruitment of TRAPP/COPII is likely to be 
a piggyback mechanism linked to the ability of TRAPPC2 to interact with multiple 
RNA binding proteins, a mechanism that has been described for many other 
components of SGs (Anderson and Kedersha, 2008). 
 
The functional consequences of the recruitment of TRAPP/COPII to SGs are 
double-edged since on the one hand they impact on the function and organization 
of the secretory pathway while on the other they impact on the composition and 
function of the SGs. The recruitment/sequestering of two complexes, one with a 
driving role in ER export and another acting as a GEF for Rab1, a master GTPase 
orchestrating the organization of the Golgi complex, induces, not surprisingly, 
both a slow-down of the ER-to-Golgi transport of newly synthesized proteins and 
 15 
the disorganization of the structure of the Golgi complex. Importantly, both of 
these changes are completely reversible since ER export resumes and proper Golgi 
morphology is restored upon stress removal and relocation of the two complexes 
to their natural sites. While the sequestering of TRAPP/COPII impinges mainly on 
ER export and on the early secretory pathway, the recently described 
delocalization of the TGN-located PARP12 to SGs affects mainly late Golgi 
compartments (Catara et al., 2017). 
 
The consequence of sequestering of TRAPP/COPII to SGs, i.e., an immediate halt 
in secretory activity, an energetically costly process, can be seen as a way to limit 
energy expenditure upon acute stress but also to prevent the ER export of newly 
synthesized proteins that might have been damaged/misfolded by the acute stress 
before an adequate UPR is installed and becomes operative.  
 
An unanticipated feature of the stress response we have reported here is its 
dependence on the proliferation status of the cells. Indeed, the sequestration of 
TRAPP and COPII to SGs occurs only when the acute stress impinges on actively 
proliferating cells. Cells with a slow/halted proliferation rate still form SGs in 
response to acute stress stimuli, but do not delocalize TRAPP/COPII from their 
steady state sites, i.e., the ERES, to SGs.  We have used multiple strategies to slow 
down (or halt) proliferation: nutrient deprivation, a high cell density, or a switch 
from a proliferation to a differentiation program. Under all circumstances we 
observed a very tight correlation between the extent of recruitment of 
TRAPP/COPII to SGs and the proliferation rate, indicating that acquisition of 
components of the secretory machinery does not occur by default as a 
consequence of the assembly of the SGs but is an active process that is subjected 
to specific regulation. We found that this regulation involves the activity of 
CDK1&2, since CDK1&2 inhibitors and/or CDK1&2 downregulation prevented the 
relocation of TRAPP/COPII to SGs. With regard to relevant mechanisms controlled 
by CDKs, these may be multiple and co-operative. Some components of SGs are 
CDKs targets, including some of the TRAPPC2 interactors (Moujalled et al., 2015) 
and the CDK-dependent phosphorylation of these targets has been shown to 
impinge on the composition of the SGs. Additionally, the function of the ERES and 
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some of the components of the COPII coat are controlled by CDKs. A member of 
the CDK family, PCTAIRE, is recruited to ERES via its interaction with Sec23 and 
controls ER export (Palmer et al., 2005) and Sec31, a component and a regulator 
of COPII cycle, is a substrate for CDKs in yeast and in Trypanosoma, and, as we 
have shown here, also in mammalian cells (Figure 7C,D). Further, the 
phosphorylation of Sec31 in response to growth factor and mitogenic signals has 
also been reported (Dephoure et al. 2008; Olsen et al., 2006). 
.  
We have shown here that, consistent with the described role of Sec31 as a co-GAP 
for Sar1, Sec31 function is required to control the COPII cycle at the ERES, since 
Sec31 depletion induces a tighter association of the inner COPII components 
Sec23-24 with ERES and prevents their translocation to SGs. In fact, our results 
indicate that the extent of translocation of COPII/TRAPP to SGs is directly 
proportional to their cycling rate at the ERES membranes. We have shown that 
this rate is diminished by CDK inhibitors, but also, importantly, in starved cells as 
compared to actively proliferating cells. The regulation of the cycling rate of ERES 
components by growth factors and growth factor-dependent signaling has been 
reported in large scale and focused studies (Farhan et al., 2010; Tillmann et al., 
2015). Thus, the activity of the ERES, as measured by their number and by the rate 
of cycling of ERES components, is stimulated under conditions that require 
maximal efficiency of output from the ER, such as during cell size increase and 
organelle expansion. If cells are affected by an acute stress under these conditions, 
then the fast cycling COPII components in actively growing cells are temporarily 
sequestered to the SGs to instantly slow down ER output and reduce energy 
consumption. By contrast, we found that nutrient starvation imposes a slow-down 
of the COPII/TRAPP cycle and, by doing so, prevents COPII/TRAPP translocation 
to SGs. Indeed, a profound remodeling of ERES during starvation has been 
reported where COPII and TRAPP are diverted from their role in the secretory 
pathway to their role in autophagosome biogenesis (Ge et al., 2017; Imai et al., 
2016; Kim et al., 2016; Lamb et al., 2016; Ramírez-Peinado et al., 2017; van 
Leeuwen et al., 2018). We hypothesize that the rate of cycling of COPII at its site of 
action in autophagosome biogenesis is lower than its rate at the “conventional” 
ERES under feeding conditions and this in turn may prevent its sequestration to 
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SGs upon stress exposure. The lack of sequestration of TRAPP/COPII in starved 
cells exposed to stress would allow COPII and TRAPP to function and contribute 
to the autophagy process, a process that leads to nutrient recycling and energy 
production, desirable events in cells exposed to stress. 
 
Finally, we have shown that TRAPP is not a “passive” constituent of SGs since its 
recruitment to SGs is required for the proper maturation of these membrane-less 
organelles. Preventing the recruitment of TRAPP to SGs or depleting TRAPP does 
not impair the formation of SGs per se but hampers their maturation, as evaluated 
by their size (smaller SGs in the absence of TRAPP) and composition. In particular, 
key signaling components, such as RACK1 and Raptor, are no longer recruited to 
SGs in TRAPP-depleted cells. The consequences of impaired SG maturation in 
TRAPP-depleted cells consist in lower resistance to stress and a higher tendency 
to undergo apoptosis. This role of TRAPP in conferring higher resistance to stress, 
especially in highly proliferating cells, could be extremely relevant in proliferating 
chondrocytes, which are key components of the epiphyseal growth plate and 
whose malfunction, as a consequence of ill-tolerated repetitive stresses, could lead 
to the progressive delayed growth observed in the spondyloepiphyseal dysplasia 
tarda, caused by mutations in TRAPPC2. 
The mechanisms underlying the TRAPP-dependent maturation of SGs remain to 
be identified. Two possible non-exclusive scenarios are worthy of consideration, 
the engagement of specific protein-protein interactions between TRAPP 
components and signaling molecules or a central role of TRAPP, originally 
identified as a tethering complex, in mediating tethering/coalescence of smaller 
SGs into larger ones, which might be the only ones competent for recruiting 
signaling molecules.  
 
Supplementary Materials  
 
Materials and methods 
Reagents and antibodies  
Primary antibodies used in this study were: monoclonal mouse antibody anti-
G3BP (BD Transduction Laboratories cat. no. 611126), monoclonal mouse 
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antibody anti-TRAPPC5 (Abnova cat. no. H00126003-A01), polyclonal goat 
antibody anti-eIF3 (Santa Cruz cat. no. sc-16377), rabbit polyclonal antibody anti-
Sec24C (Sigma-Aldrich cat. no. HPA040196), mouse monoclonal anti-flag (Sigma-
Aldrich cat. no. F1804), rabbit polyclonal antibody anti-phosphor-Ser CDK 
substrates motif (Cell signaling cat. no. 9477), mouse monoclonal anti-GM130 (BD 
Transduction Laboratories cat. no. 610823), human monoclonal antibody anti-
Rab1-GTP (Adipogen cat. no. AG-27B-0006), sheep polyclonal anti-TGN46 
(Serotec cat. no. AHP500), rabbit polyclonal antibody anti-Sec31A (Sigma-Aldrich 
cat. no. HPA005457), mouse monoclonal antibody anti-Retinoblastoma (Cell 
Signaling cat. no. 9309), rabbit polyclonal antibody anti-phospho Retinoblastoma 
(Cell Signaling cat. no. 9516), rabbit polyclonal antibody anti-eiF2⍺ (Cell Signaling 
cat. no. 9722), rabbit polyclonal antibody anti-phospho-eiF2⍺ (ser51) (Cell 
Signaling cat. no. 3597), mouse monoclonal antibody anti-puromycin (Millipore 
cat.no. MABE343), rabbit polyclonal anti- -actin (Sigma-Aldrich cat. no. A2066), 
mouse monoclonal antibody anti-GAPDH (Santa Cruz cat. no. sc-32233). 
Synaptopodin. Polyclonal antibodies against TRAPPC2 and TRAPPC3 (Venditti et 
al., 2012) were obtained in our labs. 
Media, serum and reagents for tissue culture were purchased from Thermo Fisher 
Scientific.  
Sodium arsenite was from Sigma-Aldrich (cat. no. S7400), Flavopirodol 
hydrochloride (cat. no. S2679), SNS-032 (BMS-387032) (cat. no. S1145) and 
Dinaciclib (SCH727965) (cat. no. S2768) were purchased from Sellekchem. 
Puromycin was purchased from Sigma-Aldrich (cat.no. A1113802).  
 
Plasmid construction  
TRAPPC3-GFP, Sec23A-GFP, Rab1-GFP, OCRL-GFP, Rab5-GFP and Rab7-GFP were 
obtained as previously described (De Leo et al., 2016; Venditti et al., 2012; 
Vicinanza et al., 2011). 
 
Cell culture, transfection, and RNA interference  
HeLa cells were grown in high glucose (4,500 mg/L) DMEM supplemented with 
10% FCS. U2OS were grown in McCoy’s supplemented with 20% FCS. Human 
fibroblasts were grown in DMEM and M199 (1:4) supplemented with 10% FCS. 
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Podocytes were grown in RPMI-1640 supplemented with 10% Insulin-
transferrin-Selenium (ITS) and 10% FCS.  
For transfection of DNA plasmids, HeLa cells were transfected using either 
TransIT-LT1 (Mirus Bio LLC, for BioID2 experiment) or JetPEI (Polyplus, for 
immunofluorescence analysis) as transfection reagents, and the expression was 
maintained for 16 hr before processing. Microinjection of TRAPPC3 antibody was 
performed as described (Venditti et al., 2012). 
siRNA sequences used in this study are listed in Fig. SX. HeLa cells were treated 
for 72 hr with Oligofectamine (Life Technologies) for direct transfection.  
 
Stressing cells 
Mammalian cells were treated with 300 uM SA for 30 min at 37°C/5% CO2 (unless 
otherwise stated). Heat treatment (44 C) was for 45 min. 
 
High content screening  
HeLa cells were plated in 384-well culture plates. The day after, a kinase inhibitor 
library, purchased from Selleckchem, was dispensed using a liquid-handler 
system (Hamilton) to give a final concentration of 10 µM. 150 minutes after drug 
administration, cells were treated with sodium arsenite (300 µM) for 30 min at 
37°C in the presence of compounds. Finally, samples were fixed for 10 min at room 
temperature by adding 1 volume of 4% PFA (paraformaldehyde in PBS) to the 
growth medium and stained with the appropriate antibodies.  
For image acquisition, at least 25 images per field were acquired per well of the 
384-well plate using confocal automated microscopy (Opera high content system; 
Perkin-Elmer). A dedicated script was developed to perform the analysis of 
Sec24C localization on the different images (Harmony and Acapella software; 
Perkin-Elmer). The script calculated the co-localization value of Sec24C with the 
SG marker (G3BP). The results were normalized using positive (mock cells 
exposed to SA) control samples in the same plate.  
P-values were calculated on the basis of mean values from three independent 
wells. The data are represented as a percentage of Sec24C recruitment in the 
control cells (100%) using Excel (Microsoft) and Prism software (GraphPad 
software). 
 20 
 
Immunofluorescence microscopy 
 
Electron microscopy  
 
Digitonin Assay  
HeLa cells were exposed to SA or treated with Dinaciclib (10 µM). After treatment, 
cells were washed twice with permeabilization buffer (25mM HEPES, 125 mM 
CH3COOK, 2.5 mM Mg(CH3COO)2, 5 mM EGTA, 1mM DTT) and then 
permeabilized in PB buffer supplemented with 30 µg/mL of digitonin plus the 
indicated antibody to visualize permeabilized cells. To analyze Sec24C association 
with SGs, digitonin was left for 6 min at room temperature. Cells were then washed 
three times with PB buffer and left in PB buffer for 10 min at RT. Finally, samples 
were fixed with 4% PFA and processed for IF. To analyse Sec24C association at 
ERES in the presence of Dinaciclib, cells were fixed for 2 min after digitonin 
permeabilization. 
 
Puromycin Assay  
The puromycin (PMY) assay was modified from Davis (David?) et al., JCB 2012. In 
brief, mock, TRAPPC2-KD or TRAPPC3-KD HeLa cells were exposed to SA (500 µM, 
30 min) in DMEM 10% FCS. Cells were washed three times in DMEM 1X and 
incubated with 9 µM PMY in DMEM for 5 min at 37°C. Samples were lysed in RIPA 
buffer and processed for Western blot analysis with the anti-puromycin antibody.  
 
Transport assay  
VSVG-mEOS2-2XUVR8 was a gift from Matthew Kennedy (AddGene plasmid # 
49803). HeLa cells were transfected with the plasmid for 16 hr and treated with 
SA for the indicated times. A UV-A lamp was used to illuminate samples (4 pulses, 
15 sec each). After the light pulses, cells were left for 10 min at 37°C, then fixed 
with a volume of 4% PFA and processed for immunofluorescence. 
The PC-I transport assay was performed in human fibroblasts as previously 
described (Venditti et al., 2012). For our purposes, cells were treated with SA 
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(300µM) for 120 min at 40°C and analyzed 10 min after the temperature switch 
(40 to 32°C). Cells were then fixed and stained with appropriate antibodies. 
 
Immunoprecipitation  
For the studies of TRAPPC2 interactors, HeLa cells were transfected with the 
TRAPPC2-3XFLAG and 3XFLAG constructs. 16 hr post-transfection, cells were 
lysed with lysis buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.5% 
Lauryl Maltoside, protease and phosphatase inhibitors). 
Cell extracts from control transfected HeLa cells or cells expressing TRAPPC2-
3XFLAG were immune-precipitated for 5 hr at 4°C using M2-flag agarose beads. 
Immune-precipitates were analysed by Western blot or by LC-MS/MS (Central 
Proteomics Facility, Sir William Dunn Pathology School, Oxford University).  
HeLa cells or podocytes were used to analyse Sec31 phosphorylation status. IP of 
HeLa cells: cells were plated in 15 mm plates. The day after, samples were treated 
with Dinaciclib (10 µM in DMSO) for 150 min and with SA (300 µM, 10 min) alone 
or in combination. Cells were then lysed with RIPA buffer (20mM Tris-HCl pH 7.5, 
150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 
protease and phosphatase inhibitors). Cells extracts were immune-precipitated 
for 30 min at 4°C using the anti-Sec31A antibody. Finally, protein-A Sepharose 
beads were added to the samples and left for 45 min at 4°C. Samples were 
analyzed by Western blot using the antibodies indicated in the main text. IP of 
podocytes: growing and differentiated podocytes were lysed and processed as 
described for HeLa cells.  
 
Functional annotation of the putative TRAPPC2 protein partners  
TRAPPC2-FLAG IP samples were compared with the proteins 
immunoprecipitated in the control IP (refer to Supplementary Table……): 427 
proteins were specifically immunoprecipitated in TRAPPC2-FLAG samples. 
Moreover, 113 were enriched in the TRAPPC2-FLAG IP samples versus the control 
IP (ratio >2). Functional Annotation analysis (Dennis et al., 2003; W. Huang et al., 
2009) was used to group the putative TRAPPC2 protein partners according to 
Molecular Function (MF). The DAVID online tool (DAVID Bioinformatics 
Resources 6.7) was used restricting the output to all MF terms (MF_FAT). Of note, 
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we found that 251 out of the total 539 proteins were annotated as RNA-binding 
proteins (GO:0003723) (Ashburner et al., 2000). 
 
Cell cycle analysis by flow cytometry  
HeLa cells were harvested and resuspended in PBS. For the fixation, a 9-fold 
volume of 70% ethanol was added and incubated a 4°C for at least 1hr. Next, cells 
were centrifuged, washed in PBS and resuspended in PBS containing RNase A 0.1 
mg/ml. After incubation for 1hr at 37°C, propidium iodide was added to a final 
concentration of 10 µg/ml and samples were analyzed in an Accuri C6 flow 
cytometer. 
 
Cell proliferation analysis by High Content Imaging  
Cell cycle analysis by high content imaging was performed using the Click-iT Plus 
EdU Alexa Fluor 488 Imaging Kit (Life Technologies) according to the 
manufacturer’s instructions. Images were acquired with an automated confocal 
microscopy (Opera System, Perkin-Elmer) and analyzed through Columbus Image 
Data Storage and Analysis System (Perkin-Elmer). Nuclear intensity of EdU (5-
ethynyl-2'-deoxyuridine, a nucleoside analog of thymidine) in EdU-positive nuclei 
(S-phase cells) was used as a measure of DNA replication rate. 
 
Yeast Methods  
The centromeric plasmid pUG23-Bet3-GFP (His selection) was described 
previously (Mahfouz et al., 2012). A Pab1-mRFP expressing plasmid was 
constructed by PCR amplification of the Pab1 gene plus 419 bp of the promoter 
region from yeast genomic DNA and cloning into the vector backbone of the 
centromeric plasmid pUG35 (Ura selection), removing the Met25 promoter and 
replacing GFP with mRFP, using standard cloning techniques. Yeast cells (BY4743) 
were transformed with both plasmids and grown in –Ura-His media with 2% 
Dextrose at 30°C to early log phase. Stress granules were induced by incubating 
cells at 46°C for 10 min (Riback et al., 2017) and observed immediately on an 
LSM800 microscope. 
 
 
 23 
References 
Anderson P, Kedersha N. 2008. Stress granules: the Tao of RNA triage. Trends 
Biochem Sci 33:141–150. doi:10.1016/j.tibs.2007.12.003 
 
Anderson P, Kedersha N. 2002. Stressful initiations. J Cell Sci 115:3227–3234. 
Arimoto K, Fukuda H, Imajoh-Ohmi S, Saito H, Takekawa M. 2008. Formation of 
stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. 
Nat Cell Biol 10:1324–1332. doi:10.1038/ncb1791 
 
Asghar U, Witkiewicz AK, Turner NC, Knudsen ES. 2015. The history and future of 
targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov 14:130–
146. doi:10.1038/nrd4504 
 
Aulas A, Fay MM, Szaflarski W, Kedersha N, Anderson P, Ivanov P. 2017. Methods 
to Classify Cytoplasmic Foci as Mammalian Stress Granules. J Vis Exp JoVE. 
doi:10.3791/55656 
 
Bi X, Mancias JD, Goldberg J. 2007. Insights into COPII Coat Nucleation from the 
Structure of Sec23•Sar1 Complexed with the Active Fragment of Sec31. Dev Cell 
13:635–645. doi:10.1016/j.devcel.2007.10.006 
 
Catara G, Grimaldi G, Schembri L, Spano D, Turacchio G, Lo Monte M, Beccari AR, 
Valente C, Corda D. 2017. PARP1-produced poly-ADP-ribose causes the PARP12 
translocation to stress granules and impairment of Golgi complex functions. Sci Rep 
7:14035. doi:10.1038/s41598-017-14156-8 
 
Chen D, Gibson ES, Kennedy MJ. 2013. A light-triggered protein secretion system. J 
Cell Biol 201:631–640. doi:10.1083/jcb.201210119 
D’Arcangelo JG, Stahmer KR, Miller EA. 2013. Vesicle-mediated export from the 
ER: COPII coat function and regulation. Biochim Biophys Acta 1833:2464–2472. 
doi:10.1016/j.bbamcr.2013.02.003 
 
De Leo MG, Staiano L, Vicinanza M, Luciani A, Carissimo A, Mutarelli M, Di 
Campli A, Polishchuk E, Di Tullio G, Morra V, Levtchenko E, Oltrabella F, Starborg 
T, Santoro M, Di Bernardo D, Devuyst O, Lowe M, Medina DL, Ballabio A, De 
Matteis MA. 2016. Autophagosome-lysosome fusion triggers a lysosomal response 
mediated by TLR9 and controlled by OCRL. Nat Cell Biol 18:839–850. 
doi:10.1038/ncb3386 
 
Dephoure N, Zhou C, Villén J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP. 
2008 A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 
105(31):10762-7 
 
Farhan H, Wendeler MW, Mitrovic S, Fava E, Silberberg Y, Sharan R, Zerial M, 
Hauri H-P. 2010. MAPK signaling to the early secretory pathway revealed by 
kinase/phosphatase functional screening. J Cell Biol 189:997–1011. 
doi:10.1083/jcb.200912082 
 
Ge L, Zhang M, Kenny SJ, Liu D, Maeda M, Saito K, Mathur A, Xu K, Schekman R. 
2017. Remodeling of ER-exit sites initiates a membrane supply pathway for 
 24 
autophagosome biogenesis. EMBO Rep 18:1586–1603. 
doi:10.15252/embr.201744559 
 
Gedeon AK, Colley A, Jamieson R, Thompson EM, Rogers J, Sillence D, Tiller GE, 
Mulley JC, Gécz J. 1999. Identification of the gene (SEDL) causing X-linked 
spondyloepiphyseal dysplasia tarda. Nat Genet 22:400–404. doi:10.1038/11976 
 
Gorur A, Yuan L, Kenny SJ, Baba S, Xu K, Schekman R. 2017. COPII-coated 
membranes function as transport carriers of intracellular procollagen I. J Cell Biol 
216:1745–1759. doi:10.1083/jcb.201702135 
 
Harripaul R, Vasli N, Mikhailov A, Rafiq MA, Mittal K, Windpassinger C, Sheikh 
TI, Noor A, Mahmood H, Downey S, Johnson M, Vleuten K, Bell L, Ilyas M, Khan 
FS, Khan V, Moradi M, Ayaz M, Naeem F, Heidari A, Ahmed I, Ghadami S, Agha Z, 
Zeinali S, Qamar R, Mozhdehipanah H, John P, Mir A, Ansar M, French L, Ayub M, 
Vincent JB. 2018. Mapping autosomal recessive intellectual disability: combined 
microarray and exome sequencing identifies 26 novel candidate genes in 192 
consanguineous families. Mol Psychiatry 23:973–984. doi:10.1038/mp.2017.60 
 
Henrotin YE, Bruckner P, Pujol J-PL. 2003. The role of reactive oxygen species in 
homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11:747–755. 
 
Holt LJ, Tuch BB, Villén J, Johnson AD, Gygi SP, Morgan DO. 2009. Global 
analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. 
Science 325:1682–1686. doi:10.1126/science.1172867 
 
Hu H, Gourguechon S, Wang CC, Li Z. 2016. The G1 Cyclin-dependent Kinase 
CRK1 in Trypanosoma brucei Regulates Anterograde Protein Transport by 
Phosphorylating the COPII Subunit Sec31. J Biol Chem 291:15527–15539. 
doi:10.1074/jbc.M116.715185 
 
Imai K, Hao F, Fujita N, Tsuji Y, Oe Y, Araki Y, Hamasaki M, Noda T, Yoshimori T. 
2016. Atg9A trafficking through the recycling endosomes is required for 
autophagosome formation. J Cell Sci 129:3781–3791. doi:10.1242/jcs.196196 
 
Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R. 2016. ATPase 
modulated stress granules contain a diverse proteome and substructure. Cell 164:487–
498. doi:10.1016/j.cell.2015.12.038 
 
Kapetanovich L, Baughman C, Lee TH. 2005. Nm23H2 Facilitates Coat Protein 
Complex II Assembly and Endoplasmic Reticulum Export in Mammalian Cells. Mol 
Biol Cell 16:835–848. doi:10.1091/mbc.E04-09-0785 
 
Khattak NA, Mir A. 2014. Computational analysis of TRAPPC9: candidate gene for 
autosomal recessive non-syndromic mental retardation. CNS Neurol Disord Drug 
Targets 13:699–711. 
 
Kim JJ, Lipatova Z, Segev N. 2016. TRAPP Complexes in Secretion and Autophagy. 
Front Cell Dev Biol 4:20. doi:10.3389/fcell.2016.00020 
 
 25 
Koehler K, Milev MP, Prematilake K, Reschke F, Kutzner S, Jühlen R, Landgraf D, 
Utine E, Hazan F, Diniz G, Schuelke M, Huebner A, Sacher M. 2017. A novel 
TRAPPC11 mutation in two Turkish families associated with cerebral atrophy, global 
retardation, scoliosis, achalasia and alacrima. J Med Genet 54:176–185. 
doi:10.1136/jmedgenet-2016-104108 
 
Koreishi M, Yu S, Oda M, Honjo Y, Satoh A. 2013. CK2 Phosphorylates Sec31 and 
Regulates ER-To-Golgi Trafficking. PloS One 8:e54382. 
doi:10.1371/journal.pone.0054382 
 
Lamb CA, Nühlen S, Judith D, Frith D, Snijders AP, Behrends C, Tooze SA. 2016. 
TBC1D14 regulates autophagy via the TRAPP complex and ATG9 traffic. EMBO J 
35:281–301. doi:10.15252/embj.201592695 
 
Li C, Luo X, Zhao S, Siu GK, Liang Y, Chan HC, Satoh A, Yu SS. 2017. COPI-
TRAPPII activates Rab18 and regulates its lipid droplet association. EMBO J 36:441–
457. doi:10.15252/embj.201694866 
 
Lord C, Bhandari D, Menon S, Ghassemian M, Nycz D, Hay J, Ghosh P, Ferro-
Novick S. 2011. Sequential interactions with Sec23 control the direction of vesicle 
traffic. Nature 473:181–186. doi:10.1038/nature09969 
 
Malumbres M. 2014. Cyclin-dependent kinases. Genome Biol 15:122. 
Milev MP, Graziano C, Karall D, Kuper WFE, Al-Deri N, Cordelli DM, Haack TB, 
Danhauser K, Iuso A, Palombo F, Pippucci T, Prokisch H, Saint-Dic D, Seri M, 
Stanga D, Cenacchi G, van Gassen KLI, Zschocke J, Fauth C, Mayr JA, Sacher M, 
van Hasselt PM. 2018. Bi-allelic mutations in TRAPPC2L result in a 
neurodevelopmental disorder and have an impact on RAB11 in fibroblasts. J Med 
Genet 55:753–764. doi:10.1136/jmedgenet-2018-105441 
 
Milev MP, Grout ME, Saint-Dic D, Cheng Y-HH, Glass IA, Hale CJ, Hanna DS, 
Dorschner MO, Prematilake K, Shaag A, Elpeleg O, Sacher M, Doherty D, 
Edvardson S. 2017. Mutations in TRAPPC12 Manifest in Progressive Childhood 
Encephalopathy and Golgi Dysfunction. Am J Hum Genet 101:291–299. 
doi:10.1016/j.ajhg.2017.07.006 
 
Mironov AA, Beznoussenko GV, Nicoziani P, Martella O, Trucco A, Kweon H-S, 
Giandomenico DD, Polishchuk RS, Fusella A, Lupetti P, Berger EG, Geerts WJC, 
Koster AJ, Burger KNJ, Luini A. 2001. Small cargo proteins and large aggregates can 
traverse the Golgi by a common mechanism without leaving the lumen of cisternae. J 
Cell Biol 155:1225–1238. doi:10.1083/jcb.200108073 
 
Mohamoud HS, Ahmed S, Jelani M, Alrayes N, Childs K, Vadgama N, Almramhi 
MM, Al-Aama JY, Goodbourn S, Nasir J. 2018. A missense mutation in TRAPPC6A 
leads to build-up of the protein, in patients with a neurodevelopmental syndrome and 
dysmorphic features. Sci Rep 8:2053. doi:10.1038/s41598-018-20658-w 
 
Moujalled D, James JL, Yang S, Zhang K, Duncan C, Moujalled DM, Parker SJ, 
Caragounis A, Lidgerwood G, Turner BJ, Atkin JD, Grubman A, Liddell JR,  
 
 26 
Olsen JV1, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M 2006 
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks 
Cell. 2006;127(3):635-48 
 
Proepper C, Boeckers TM, Kanninen KM, Blair I, Crouch PJ, White AR. 2015. 
Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic 
accumulation of TDP-43. Hum Mol Genet 24:1655–1669. doi:10.1093/hmg/ddu578 
 
Palmer KJ, Konkel JE, Stephens DJ. 2005. PCTAIRE protein kinases interact directly 
with the COPII complex and modulate secretory cargo transport. J Cell Sci 118:3839–
3847. doi:10.1242/jcs.02496 
 
Protter DSW, Parker R. 2016. Principles and Properties of Stress Granules. Trends 
Cell Biol 26:668–679. doi:10.1016/j.tcb.2016.05.004 
 
Ramírez-Peinado S, Ignashkova TI, van Raam BJ, Baumann J, Sennott EL, Gendarme 
M, Lindemann RK, Starnbach MN, Reiling JH. 2017. TRAPPC13 modulates 
autophagy and the response to Golgi stress. J Cell Sci 130:2251–2265. 
doi:10.1242/jcs.199521 
 
Sacher M, Shahrzad N, Kamel H, Milev MP. 2018. TRAPPopathies: An emerging set 
of disorders linked to variations in the genes encoding transport protein particle 
(TRAPP)-associated proteins. Traffic Cph Den. doi:10.1111/tra.12615 
 
Saleem MA, O'Hare MJ, Reiser J et al. 2002 A conditionally immortalized human 
podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. 
Nephrol. 13: 630–38.  
 
Saurus P, Kuusela S, Dumont V, Lehtonen E, Fogarty CL, Lassenius MI, Forsblom C, 
Lehto M, Saleem MA, Groop P-H, Lehtonen S. 2016. Cyclin-dependent kinase 2 
protects podocytes from apoptosis. Sci Rep 6:21664. doi:10.1038/srep21664 
 
Scrivens PJ, Noueihed B, Shahrzad N, Hul S, Brunet S, Sacher M. 2011. C4orf41 and 
TTC-15 are mammalian TRAPP components with a role at an early stage in ER-to-
Golgi trafficking. Mol Biol Cell 22:2083–2093. doi:10.1091/mbc.E10-11-0873 
 
Takahashi M, Higuchi M, Matsuki H, Yoshita M, Ohsawa T, Oie M, Fujii M. 2013. 
Stress Granules Inhibit Apoptosis by Reducing Reactive Oxygen Species Production. 
Mol Cell Biol 33:815–829. doi:10.1128/MCB.00763-12 
 
Thedieck K, Holzwarth B, Prentzell MT, Boehlke C, Kläsener K, Ruf S, Sonntag AG, 
Maerz L, Grellscheid S-N, Kremmer E, Nitschke R, Kuehn EW, Jonker JW, Groen 
AK, Reth M, Hall MN, Baumeister R. 2013. Inhibition of mTORC1 by Astrin and 
Stress Granules Prevents Apoptosis in Cancer Cells. Cell 154:859–874. 
doi:10.1016/j.cell.2013.07.031 
 
Tiller et al., Am. J. Hum. Genet. 68:1398–1407,2001 
 
Tillmann KD, Reiterer V, Baschieri F, Hoffmann J, Millarte V, Hauser MA, Mazza 
A, Atias N, Legler DF, Sharan R, Weiss M, Farhan H. 2015. Regulation of Sec16 
 27 
levels and dynamics links proliferation and secretion. J Cell Sci 128:670–682. 
doi:10.1242/jcs.157115 
 
Tisdale EJ, Bourne JR, Khosravi-Far R, Der CJ, Balch WE. 1992. GTP-binding 
mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the 
endoplasmic reticulum to the Golgi complex. J Cell Biol 119:749–761. 
 
van Leeuwen W, van der Krift F, Rabouille C. 2018. Modulation of the secretory 
pathway by amino-acid starvation. J Cell Biol 217:2261–2271. 
doi:10.1083/jcb.201802003 
 
Venditti R, Scanu T, Santoro M, Di Tullio G, Spaar A, Gaibisso R, Beznoussenko 
GV, Mironov AA, Mironov A, Zelante L, Piemontese MR, Notarangelo A, Malhotra 
V, Vertel BM, Wilson C, De Matteis MA. 2012. Sedlin controls the ER export of 
procollagen by regulating the Sar1 cycle. Science 337:1668–1672. 
doi:10.1126/science.1224947 
 
Vicinanza M, Di Campli A, Polishchuk E, Santoro M, Di Tullio G, Godi A, 
Levtchenko E, De Leo MG, Polishchuk R, Sandoval L, Marzolo M-P, De Matteis 
MA. 2011. OCRL controls trafficking through early endosomes via PtdIns4,5P₂-
dependent regulation of endosomal actin. EMBO J 30:4970–4985. 
doi:10.1038/emboj.2011.354 
 
Westlake CJ, Baye LM, Nachury MV, Wright KJ, Ervin KE, Phu L, Chalouni C, 
Beck JS, Kirkpatrick DS, Slusarski DC, Sheffield VC, Scheller RH, Jackson PK. 
2011. Primary cilia membrane assembly is initiated by Rab11 and transport protein 
particle II (TRAPPII) complex-dependent trafficking of Rabin8 to the centrosome. 
Proc Natl Acad Sci U S A 108:2759–2764. doi:10.1073/pnas.1018823108 
 
Wheeler JR, Matheny T, Jain S, Abrisch R, Parker R. n.d. Distinct stages in stress 
granule assembly and disassembly. eLife 5. doi:10.7554/eLife.18413 
 
Wilson BS, Nuoffer C, Meinkoth JL, McCaffery M, Feramisco JR, Balch WE, 
Farquhar MG. 1994. A Rab1 mutant affecting guanine nucleotide exchange promotes 
disassembly of the Golgi apparatus. J Cell Biol 125:557–571. 
 
Yamasaki A, Menon S, Yu S, Barrowman J, Meerloo T, Oorschot V, Klumperman J, 
Satoh A, Ferro-Novick S. 2009. mTrs130 is a component of a mammalian TRAPPII 
complex, a Rab1 GEF that binds to COPI-coated vesicles. Mol Biol Cell 20:4205–
4215. doi:10.1091/mbc.e09-05-0387 
 
Yu S, Satoh A, Pypaert M, Mullen K, Hay JC, Ferro-Novick S. 2006. mBet3p is 
required for homotypic COPII vesicle tethering in mammalian cells. J Cell Biol 
174:359–368. doi:10.1083/jcb.200603044 
 
Zacharogianni M, Aguilera-Gomez A, Veenendaal T, Smout J, Rabouille C. n.d. A 
stress assembly that confers cell viability by preserving ERES components during 
amino-acid starvation. eLife 3. doi:10.7554/eLife.04132 
 
Zou S, Liu Y, Zhang XQ, Chen Y, Ye M, Zhu X, Yang S, Lipatova Z, Liang Y, 
 28 
Segev N. 2012. Modular TRAPP complexes regulate intracellular protein trafficking 
through multiple Ypt/Rab GTPases in Saccharomyces cerevisiae. Genetics 191:451–
460. doi:10.1534/genetics.112.139378 
 
Zuscik MJ, Hilton MJ, Zhang X, Chen D, O’Keefe RJ. 2008. Regulation of 
chondrogenesis and chondrocyte differentiation by stress. J Clin Invest 118:429–438. 
doi:10.1172/JCI34174 
 
 
 
 
  
 
  
 29 
Figure legends 
 
 
 
 
Figure 1. The TRAPP complex is recruited to stress granules. (A,B) 
Localization of endogenous TRAPPC2 under steady state conditions or after 
sodium arsenite (SA) treatment in (A) a rat chondrosarcoma cell line (300 µM, 1 
hr) and (B) in HeLa cells (300 µM, 30 min). Fluorescence microscopy of fixed cells 
using antibodies against TRAPPC2, eIF3 (to label SGs), Sec31 (to label ERES). DAPI 
(blue). Small panels in (A) show details and merge of boxed areas. (C) Localization 
of endogenous TRAPPC1 and of GFP-TRAPPC3 to eIF3-labeled SGs in HeLa cells 
after SA treatment. (D) Representative images of a time course analysis of 
TRAPPC2 redistribution to SGs. Cells were treated as in (B). Graph, quantification 
of TRAPPC2 localization at SGs over time (the ratio between TRAPPC2 (mean 
fluorescence intensity) in SG puncta and cytosolic TRAPPC2). Mean ± s.e.m. n = 50 
cells per experiment, N = 3. Scale bar, 10 µm in (A-D) (E) Extracts from untreated 
and SA-treated HeLa cells were fractionated by size exclusion chromatography on 
a Superose 6 column. Fractions were analyzed by Western blot using antibodies 
against endogenous TRAPPC2, TRAPPC3 and TRAPPC12 (a component of the high 
MW mammalian TRAPPIII complex, REF), and against the SG marker TIAR-1. 
TRAPP components co-fractionated with a high molecular weight complex (red 
dashed box) containing TIAR-1 in SA-treated cells.  
Figure 1—figure supplement 1. Re-localization of TRAPP to SGs is independent 
of stress stimulus and cell type. 
Figure 1—figure supplement 2. Stress-induced localization of Bet3 (TRAPPC3) 
to SGs in yeast cells. 
Figure 1—supplement video 1. Bet3 (TRAPPC3) and Pab1 at 30 C in yeast cells. 
Figure 1—supplement video 2. Bet3 (TRAPPC3) and Pab1 at 46 C in yeast cells. 
Figure 1—figure supplement 3. Association of TRAPP with SGs is reversible 
after SG disassembly. 
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Figure 2. TRAPPC2 is required for Sec23/24 relocalization to SGs. (A) HeLa 
cells, untreated or treated with SA, were fixed and visualized by fluorescence 
microscopy using anti-Sec24C Ab, anti-eIF3 Ab, and DAPI (blue). (B) 
Quantification of Sec24C redistribution to SGs over time after SA treatment (the 
ratio between Sec24C (mean fluorescence intensity) in SG puncta and cytosolic 
Sec24C). Mean ± s.e.m. n = 50 cells per experiment, N = 3. (C) Cells treated as in 
(A) stained with an antibody recognizing the coatomer I (COPI), which does not 
relocalize to SGs (see also Figure 2—figure supplement 1A-N). (D) Representative 
images of TRAPPC2 localization in Sec23AB-KD and Sec24ABCD-KD cells treated 
with SA. Cells were fixed and visualized by fluorescence microscopy using anti-
TRAPPC2 Ab, anti-G3BP Ab (to label SGs) and DAPI (blue). (E) Quantification of 
TRAPPC2 redistribution to SGs after KD of the indicated Sec23 and Sec24 
combinations, calculated as the ratio between TRAPPC2 (mean intensity) in SG 
puncta and cytosolic TRAPPC2. Mean ± s.e.m., n = 40-60 cells per experiment, N = 
3. ns: not significant. (F) Representative images of Sec24C localization at SGs 
(stained for G3BP) in TRAPPC3-KD and TRAPPC2-KD cells treated with SA. 
Depletion of TRAPP or TRAPPC2 reduces Sec24C recruitment. Graph, 
quantification of Sec24C at SGs, calculated as in (A). Mean ± s.e.m., n = 40-60 cells 
per experiment, N = 3. **** P < 0.0001.  
Figure 2—figure supplement 1. Sec24C and Sec23, but not components of other 
coat complexes or other cytosolic proteins associated with the exocytic and 
endocytic pathways associate with SGs. 
Figure 2—figure supplement 2. Sec16 does not significantly associate with SGs 
nor is it required for the recruitment of COPII to SGs.  
  
 31 
 Figure 3. TRAPP and COPII stably associate with SGs. (A) The membrane 
association of Sec24C was evaluated in non-permeabilized or permeabilized cells 
with or without SA treatment, as indicated. G3BP was used as an SG marker. Left 
panel insets, G3BP staining in non-permeabilized cells. Dashed white lines show 
the outline of permeabilized SA-untreated cells. Blue, DAPI. (B) HeLa cells 
overexpressing GFP-Sar1H79G were treated with SA and immunostained for 
Sec24C, TRAPPC2, and eIF3, as indicated. Blue, DAPI. Scale bar 10 µm. Graphs 
show quantification of Sec24C or TRAPPC2 at SGs in GFP-Sar1H79G-expressing 
cells relative to non-transfected cells. Data are the ratio between Sec24C mean 
intensity in SG puncta and Sec24C mean intensity at ERES, expressed as a 
percentage of the non-transfected cells. Mean ± s.e.m., n = 60-70); of Sec24C three 
independent experiments. ****p<0.0001. mean ± s.e.m. of TRAPPC2 one 
representative experiment. (C) Effect of Sec31A depletion on TRAPPC2 and 
Sec24C recruitment to SGs. Cells were mock-treated or KD for Sec31, treated with 
SA (300µM, 30 minutes), and then immunostained for TRAPPC2, Sec24C and eIF3 
as indicated. Scale bar, 10 µm. Graph, quantification of Sec24C and TRAPPC2 at 
SGs, calculated as in (B). Mean ± s.e.m. of TRAPPC2 and Sec24C one representative 
experiment; n=60-80. ** p<0.001, ****p<0.0001. 
Figure 3—figure supplement 1. Effect of Sec31 depletion on Sec24C localization 
at ERES.  
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 Figure 4. The association of TRAPP with SGs is mediated by its interaction 
with RNA binding proteins and is under control of CDK1/2. (A) Schematic 
representation of MS/MS analysis of TRAPPC2 interactors. 251 out of 512 (46%) 
proteins are RNA-binding proteins, including several SG proteins (yellow ellipse). 
(B) Cells were treated with 273 kinase inhibitors (10 µM) from the Sellekchem 
library and with SA, and Sec24C localization in G3BP puncta (% of total G3BP area) 
was calculated (see Materials and methods) and is reported as a percentage of the 
control (cells treated with SA alone). Gray dashed line, mean of control; gray box, 
control standard deviation (± 18.2%); dashed red line, threshold of positive hits. 
(C) Enrichment Analysis of the positive hits; for each class of inhibitor, the 
enrichment (in percentage) of compounds falling into positive hits and the 
enrichment (in percentage) in the total number of compounds was calculated and 
expressed as a ratio. (D) Evaluation of CDK kinase activity upon SA treatment. 
Western blot analysis of phosphoSer-CDK substrates in control, SA (300µM, 30 
min), Dinaciclib (10 µM, 180 min) and SA+Dinaciclib (150 min Dinaciclib and 30 
minutes SA). CDKs are hyperactivated upon oxidative stress and this activation is 
partially prevented upon CDK inhibition. Left, Western blot, right: Ponceau was 
used as loading control. Image show one representative experiments out of 3 
independent replicates. 
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 Figure 5. (A) All CDK inhibitors present in the library ranked for efficiency 
in reducing Sec24C recruitment to G3BP spots (% of the control). (A) Drug 
specificity, from high (++++) to low (+) for the different CDKs as described by 
Selleckchem and Sec24C recruitment to SGs as a percentage of control. (B) 
Analysis of Sec24C recruitment to SGs in control (MOCK), CDK1-KD, CDK2-KD and 
CDK1+2-KD HeLa cells. Data are expressed as percentage of Sec24C (mean 
intensity) in SG puncta normalized for cytosolic signal as a percentage of control 
conditions. Quantification of one representative experiments. N>100, mean ± 
s.e.m. ****p<0.0001. (C) Representative images of HeLa cells treated with the best 
three hits (Flavopiridol, SNS-032, Dinaciclib; 1µM 150 min) and then exposed to 
SA (300µM, 30 minutes), followed by immunostaining for Sec24C and G3BP. Scale 
bar, 10µm. (D) HeLa cells were treated with Flavopiridol, SNS-032, or Dinaciclib 
for 150 min at the indicated concentrations, subsequently treated with SA (300µM, 
30 min), and then immunostained for Sec24C and G3BP and imaged by OPERA. 
BS-181, a specific CDK7 inhibitor, was used as negative control. Sec24C 
localization to SGs is expressed as a percentage of the control (cells treated with 
SA alone). Dashed red line, mean of control; red box, standard deviation of control 
(± 9.8%). (E) Cells were treated as in (C) and immunostained for TRAPPC2 and 
eIF3. Scale bar, 10 µm. The graph shows the quantification of TRAPPC2 
localization in SG punta (mean intensity). Data are mean ± s.e.m. expressed as a 
percentage of TRAPPC2 signal in SGs after Flavopiridol, SNS-032 or Dinaciclib 
treatment compared to the control (cells treated with SA alone). N=3, three 
independent experiments, n=60-80 cells per experiments. ****p<0.0001.  
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 Figure 6. TRAPP and Sec23/24 migration to SGs depends on the 
proliferation state of cells. (A) HeLa cells were starved for 8 h with HBSS and 
subsequently exposed to SA (30 min, 300µM), and immunostained for Sec24C or 
TRAPPC2 and eIF3. Scale bar 10 µm. (B) Analysis of the proliferation status of the 
cells after 8 h starvation in HBSS. Left, representative images of starved and non-
starved cells using EdU incorporation (see Materials and methods) and, right, 
quantification of EdU incorporation in starved cells as a percentage of 
incorporation in control fed cells. (C) HeLa cells were seeded at different 
confluency, treated with SA and stained for Sec24C and G3BP as an SG marker. 
Scale bar, 10 µm. Flow cytometry (FACS) analysis (right panels) was performed to 
evaluate the distribution of cell cycle phases in HeLa cell populations seeded at 
different confluency. The graph shows quantification of Sec24C mean intensity in 
SG puncta normalized for the cytosolic Sec24C at the indicated cell confluency. 
Mean ± s.e.m. of a representative experiment out of n=5 biological replicates. n= 
50-80. ns, not significant; ****p<0.0001. (D) Western blot analysis of 
phosphorylated retinoblastoma (p-RB) in growing (non-differentiated) versus 
differentiated podocytes. ß-actin was used as loading control. (E) CDK kinase 
activity in growing and differentiated podocytes. Western blot using a specific 
antibody recognizing phosphoSer-CDK substrates was used on total cell lysates. 
(F) Growing and differentiated podocytes were treated with SA (300 µM, 30 min) 
and stained for TRAPPC2 or Sec24C and eIF3. Scale bar, 10µm. The graphs show 
quantification of TRAPPC2 and Sec24C (mean intensity) in SGs. Mean ± s.e.m. of 
three independent experiments ****p<0.0001. 
Figure 6—figure supplement 1. Differentiation of podocytes.  
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Figure 7. CDK1/2 modulate the COPII cycle at ERES. (A) Immunofluorescence 
images of Sec24C and TRAPPC2 in vehicle-treated and SNS-032-treated (1 µM, 3 
h) cells. Scale bar, 10 µm. Graphs show the quantification of Sec24C and TRAPPC2 
in the peri-Golgi area (mean intensity) normalized in SNS-032-treated cells 
relative to vehicle-treated cells (set as 100%). Mean ± s.e.m. of three independent 
experiments. **p<0.05****, p<0.0001. (B) HeLa cells were treated with Dinaciclib 
(1 µM, 3 h) and permeabilized or not with digitonin as described in Materials and 
methods. A GM130 antibody was added to the buffer of living cells to monitor 
permeabilization efficiency. Upper panels, non-permeabilized (NP) control cells; 
middle panels, permeabilized control cells; lower panels, permeabilized 
Dinaciclib-treated cells. Scale bar, 10 µm. (C) Quantification of Sec24C membrane 
association after CDK inhibitor treatment. Digitonin-permeabilized cells treated 
with vehicle (CTRL) or the indicated CDK inhibitor (1 µM, 3 h) were 
immunostained for Sec24C. The mean intensity of Sec24C in the perinuclear area 
normalized for the cytosolic Sec24C signal in drug-treated cells is expressed as 
fold change compared to the control; n= 60-80; mean ± s.e.m. of three independent 
experiments ****p<0.0001. (D) Cell lysates from HeLa cells treated with SA (300 
µM, 10 min), Dinaciclib (10 µM, 180 min), or their combination were 
immunoprecipitated using a Sec31 Ab. Western blots of the immunoprecipitates 
probed using the phosphor-Ser-CDK Ab (upper panel) or the anti-Sec31 Ab (lower 
panel). Note that the anti-Sec31 Ab immunoprecipitates both Sec31 isoforms. (E) 
Quantification of immunoprecipitated Sec31 from growing and differentiated 
podocytes using the phosphor-Ser-CDK Ab. Mean ± s.e.m. of three independents 
experiments. ***p<0.0007. 
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Figure 8. The recruitment of TRAPP and COPII to SGs slows down ER export 
(A) Left, control or SA-treated (500µM, 120 min) human fibroblasts (HFs) were 
incubated at 40°C for 180 min and stained for eIF3, PCI, and Sec24C. Right, the 
cells were imaged 10 min after shifting the temperature from 40°C to 32°C and 
stained for eIF3, PCI, and Giantin (to label the Golgi). Scale bar, 10 µm. (B) HeLa 
cells expressing VSV-G-UVR8 mEOS were left untreated or treated with SA for the 
indicated times and then pulsed with blue light. Images were taken 10 minutes 
after the UV pulse and processed for staining. (C) Cells were treated with SA for 
30 min, the SA was washed out, and cells were left to recover for 180 min in the 
presence of cycloheximide, followed by a blue light pulse and processing for 
staining as described in (B). (D) Quantification of VSV-G (mean intensity) in the 
Golgi area to the total VSV-G per cell under the conditions described in (B,C). Data 
are expressed as percentage of the control. Mean ± s.e.m. of three independent 
experiment. ****p<0.0001; ns, not significant.   
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Figure 9. The recruitment of TRAPP induces the fragmentation of the GC in a 
Rab1-dependent manner. (A) AiryScan images of HeLa cells treated with SA for 
the indicated times and stained with GM130 (gray). Scale bar, 10 µm. The graph 
shows quantification of Golgi particles in SA-treated cells. Mean ± s.e.m. of three 
independent experiments. n=90-100. ****p<0.0001; ns, not significant. (B) 
Control cells and cells treated with Dinaciclib (CDKi) were treated with SA and 
stained for GM130 (in gray). Insets, eIF3. Blue, nuclear DAPI staining. The graph 
shows quantification of Golgi particles in HeLa cells untreated or treated with SNS-
032, Flavopiridol, or Dinaciclib for 150 min and treated with SA (300 µM, 30 min). 
Mean ± s.e.m. of three independent experiment. ****p<0.0001. (C) Quantification 
of Golgi particles in cells plated at different percentage of confluency. Mean ± s.e.m. 
of three independent experiment. ** p<0.001; *** p<0.0002; ns: not significant. 
(D) Electron microscopy images of a cell exposed to SA (300 µM, 30 min). GC: Golgi 
complex. Scale bar 200 nm. (E) AiryScan images of HeLa cells at steady state or 
exposed to SA for the indicated times. A Rab1-GTP specific antibody was used to 
monitor Rab1-GTP activity and GM130 to stain the Golgi complex. Insets, eIF3. The 
graph shows quantification of Rab1-GTP at the Golgi complex expressed as a 
percentage of the control. Mean ± s.e.m. of three independent experiments. 
*p<0.011, **p<0.002. (F) HeLa cells transfected or not with WT GFP-Rab1B were 
left untreated or treated with SA and stained for GM130 and G3BP to monitor SGs. 
Dashed white line, WT GFP-Rab1B transfected cells. The graph shows 
quantification of Golgi particles in the different conditions. NT: non-transfected. 
Mean ± s.e.m. of three independent experiment. ****p<0.0001; n=30-50. 
 
Figure 9—figure supplement 1. TRAPPC2 migrates to SGs in Rab1 
overexpressing cells.  
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Figure 10. The TRAPP complex controls SG composition and function. (A) 
Box plot representing SG area (see Materials and methods) in mock, TRAPPC2- 
and TRAPPC3-depleted cells treated with SA. Distribution of values from three 
independent experiments. ****p<0.0001. (B) HeLa cells microinjected with 
control preimmune IgG or a TRAPPC3-specific antibody (right panels in green) 
were treated with SA. The TRAPPC3 Ab disrupts the Golgi (REF), monitored using 
an anti-TGN46 Ab. Anti-G3BP was used to stain SGs. The graph shows 
quantification of the SG area. Mean ± s.e.m. three independent experiments; n>80. 
****p<0.0001. (C) Structured Illumination Microscopy (SIM)-Super resolution 
(SR) images of endogenous TRAPPC2 and GFP-Sec23 localizing at SGs, stained for 
G3BP. Right, magnification of boxed area. (D,E) Localization of Raptor (D) and 
RACK1 (E) in mock, TRAPPC3-KD and TRAPPC2-KD HeLa cells treated with SA. 
G3BP was used to stain SGs. Scale bar, 10 µm. Each graph shows the quantification 
(mean intensity) of the respective protein in SGs spots expressed as a percentage 
of the mock. Mean ± S.D. three independent replicates. *p<0.02; **p<0.009 in (D), 
*p<0.05; ****p<0.0001 in (E). (F,G) Localization of Raptor (F) and RACK1 (G) in 
untreated cells or cells pre-treated with the indicated CDK inhibitor (1 µM, 150 
min) and then with SA (300 µM, 30 min). G3BP was used to stain SGs. Scale bar, 
10 µm. Graphs show quantification of the localization of the respective protein 
with SGs, expressed as a percentage of the control. Mean ± s.e.m. of one 
representative experiment out of three independent replicates, (n=60-80). 
****p<0.0001. (H) Analysis of cell death after an overnight recovering of HeLa 
cells treated or untreated with CDKi (SNS-032; Flavopiridol or Dinaciclib, 1 µM, 
150 min) and then treated with SA (500 µM, 3 h). Images were automatically 
acquired by OPERETTA microscopy. Values indicate the percentage of the total 
number of nuclei (stained with DAPI) positive for BoBo-3 staining. Mean ± s.d. of 
one representative experiment out of three independent replicates. ns, not 
significant, ****p<0.0001.  
Figure 10—figure supplement 1. TRAPP depletion does not affect protein 
translation inhibition caused by SA treatment.  
 Figure 1—figure supplement 1. Re-localization of TRAPP to SGs is independent 
of stress stimulus and cell type. (A) HeLa cells exposed to heat shock (44°C, 45 
min), (B) human fibroblasts treated with SA (500 µM, 180 min), (C) U2OS cells 
treated with SA (300 µM, 60 min), stained for eIF3 and TRAPPC2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 39 
Figure 1—figure supplement 2. Stress-induced localization of Bet3 (TRAPPC3) 
to SGs in yeast cells. Cells co-expressing Bet3-GFP and the stress granule marker 
RFP-PAB1 were exposed to heat shock (46°C, 10 min) and imaged. 
Figure 1—supplement video 1. 
Figure 1—supplement video 2. 
 
 
Figure 1—figure supplement 3. Association of TRAPP with SGs is reversible 
after SG disassembly. Cells were treated with SA for 30 min, the SA was washed 
out, and cells were left to recover for 120 min and processing for staining. Scale 
bar 10 µm. 
  
 
 
Figure 2—figure supplement 1. Sec24C and Sec23, but not components of other 
coat complexes or other cytosolic proteins associated with the exocytic and 
endocytic pathways associate with SGs. (A-L) Cells at steady state or treated with 
SA were visualized by fluorescence microscopy using antibodies against the 
endogenous proteins or Flag-tagged proteins, or visualizing transfected GFP-
tagged proteins, and co-stained for eIF3 or G3BP, as indicated. (M) Cells exposed 
to heat shock (44°C, 45 min) were stained for Sec24C or COPI, and G3BP. Blue, 
DAPI. (N) Schematic diagram showing the cellular location of the tested proteins 
that associate (red) or not (black) with strss granules. 
 
 
 
Figure 2—figure supplement 2. Sec16 does not significantly associate with SGs 
nor is it required for the recruitment of COPII to SGs. (A) Cells were treated with 
SA (300µM) and co-stained for endogenous Sec16 and G3BP as an SG marker.  (B) 
Cells exposed to heat shock were processed as described in (A). (C) 
Representative images of Sec24C localization in Sec16-KD cells treated with SA. 
Cells were fixed and visualized by fluorescence microscopy using anti-Sec24C Ab, 
anti-G3BP Ab, and DAPI (blue). Quantification of TRAPPC2 redistribution to SGs 
after KD calculated as the ratio between Sec24C (mean intensity) in SG puncta and 
cytosolic Sec24C. Mean ± s.e.m., n = 40-60 cells per experiment, N = 3. ns: not 
significant 
 
Figure 3—figure supplement 1. Effect of Sec31 depletion on Sec24C localization 
at ERES. Cells were mock-treated or KD for Sec31 and then immunostained for 
Sec24 and cTAGE to stain ERES. Scale bar 10µm. The graph shows the mean 
intensity of Sec24C at ERES normalized for cytosolic signal as a percentage of 
control conditions. 
 Figure 6—figure supplement 1. Differentiation of podocytes. Western blot of 
growing and differentiated podocytes. Synaptopodin was used as a differentiation 
marker, GAPDH as a loading control. 
 Figure 9—figure supplement 1. TRAPPC2 migrates to SG in Rab1 
overexpressing cells. HeLa cells overexpressing GFP-Rab1B-WT were stressed 
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with SA (300 µM 30 min) and stained for TRAPPC2 (in red) and eIF3 (in gray). 
Dashed white line: Overexpressing cells. 
 Figure 10—figure supplement 1. TRAPP depletion does not affect protein 
translation inhibition caused by SA treatment. (A) Puromycin assay (see Materials 
and methods) of MOCK, TRAPPC3 and TRAPPC2-KD HeLa cells at steady state and 
upon SA treatment. (B) Evaluation of phosphorylated eIF2a in TRAPPC3 and 
TRAPPC2 depleted cells exposed to SA. ß-actin was used as a loading control. (C) 
Structured Illumination Microscopy (SIM)-Super resolution (SR) images of 
endogenous RACK1 and G3BP. Scale bar 500 nm. 
